FDA approves first subcutaneous C1 esterase inhibitor to treat rare genetic disease
admin 5th July 2017 Uncategorised 0American Pharmacists Association News
More: FDA approves first subcutaneous C1 esterase inhibitor to treat rare genetic disease
Source: MDlinx